Uhozo

Original price was: ₹900.00.Current price is: ₹545.00.

UHOZO is an OTC NANOMEDICINE used to decrease the adverse effects as well as improving the therapeutic index of chemo and radiation treatment

UHOZO- One Stop Solution to Treat Side Effects

Benefits

Enhances effect of chemo drugs

Reduces Fatigue

Increases immunity

Improves muscle strength

Protects against infection

Prevent Liver Dysfunction

 

Ingredients

The main ingredient for UHOZO is nanosized curcumin. The best quality Curcumin has been sourced from South India and North-East India. The received curcumin undergoes quality check and then processed to nanosized curcumin at GMP facility. Curcumin is the principal therapeutic component of Turmeric (Haldi).

 

Why Choose This Product

Evidence Based Nanocurcumin

17.5 times higher absorption in the cells

Greater Benefits in combination with chemo drugs

Required in small dosages

Safe to consume- Tested

Already used by more than 500 patients

 

Experimental Results

Bioavailability/Absorption

Our nanosized curcumin (UHOZO) demonstrates 17.5 times higher absorption in cells as compared with raw curcumin. Due to significantly higher absorption, small daily dosages are required for good therapeutic ability. The results have been published with European Chemical Societies Publishing house (https://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/open.202200200).

Safety Assays

Various assays have been performed to check the safety for our nanosized curcumin (UHOZO). According to the “Globally Harmonized Classification System (GHS) for classification of chemicals which cause acute toxicity (OECD), UHOZO has been classified in GHS category 5 which is completely safe to consume.

Another heart enzyme (hERG toxicity) assessment demonstrated that UHOZO exhibits no toxicity towards heart enzyme. hERG toxicity is one of the most important safety assays for drug candidates.

Tumor Treatment Experiment

A unique approach was adopted for tumor treatment study in animals with treatment groups as (SD), UHOZO alone, UHOZO with standard drug and pre-treatment with UHOZO before development of tumor. The UHOZO along with chemo drug achieved maximum tumor reduction of more than 50% and delayed tumor development in pre-treatment group.

The above experiment demonstrates that UHOZO is a potential complementary drug for cancer patients.

What to expect/ What not to expect

What to Expect

Chemo/Radio Side effect reduction

Improvement in blood parameters

Visible improvement after 14 days of consumption

Improved immunity

Remission management

Fatigue reduction

What not to expect

Treatment of cancer without chemo drug

Immediate relief from the disease

Immediate relief from the side effects (from day 0)

0.0
Based on 0 reviews
5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%
0 of 0 reviews

Sorry, no reviews match your current selections